Similarly, an evaluation of cerebral microbleeds in gliomas has proved to be of significant value in predicting the glioma grade, IDH1 mutation, and MGMT methylation; this is affected by evaluating intratumoral susceptibility signal (ITSS) grades. Here, IDH1 is linked to central nervous system cancer.